Business
Press Release Sep 23 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled \"Strides receives USFDA approval for Icosapent Ethyl Capsules\". View Attachment","length":327,"tagName":"div"}]